PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes

Published:2019 Issue:1 Volume:25 Page:1-9
ISSN:1341-1098
Container-title:Annals of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:ATCS

Author:

Miyazawa Tomoyuki¹,Marushima Hideki¹,Saji Hisashi¹,Kojima Koji²,Hoshikawa Masahiro³,Takagi Masayuki³,Nakamura Haruhiko¹

Affiliation:

1. Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

2. Department of Clinical Regenerative Medicine and Tissue Engineering, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

3. Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan

Publisher

Editorial Committee of Annals of Thoracic and Cardiovascular Surgery

Subject

Gastroenterology,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

https://www.jstage.jst.go.jp/article/atcs/25/1/25_oa.18-00163/_pdf

Reference31 articles.

1. 1) Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.

2. 2) Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252-64.

3. 3) Jadus MR, Natividad J, Mai A, et al. Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention. Clin Dev Immunol 2012; 2012: 160724.

4. 4) Iwai Y, Ishida M, Tanaka Y, et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 2002; 99: 12293-7.

5. 5) Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 2016; 375: 1823-33.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer;Non-coding RNA Research;2025-02

2. Impact of lung adenocarcinoma subtypes on survival and timing of brain metastases;Frontiers in Oncology;2024-09-03

3. Cancer‐associated fibroblast‐derived circFARP1 modulates non–small cell lung cancer invasion and metastasis through the circFARP1/miR‐338‐3p/SOX4 axis;Clinical and Experimental Pharmacology and Physiology;2024-08-13

4. Establishment and verification of novel TNM staging system for lung mucinous adenocarcinoma;BMC Cancer;2024-07-31

5. Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer;Scientific Reports;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3